Current Faculty

The Pharmacology Department at MUSC is home to dedicated, award-winning faculty, students, researchers, and staff.

 Current Faculty

 Emeritus Professors

 Students & Alumni


Our faculty members hold 3 South Carolina Centers of Excellence Chairs, and our funded programs emphasize the department’s strengths in signaling & drug development.

Peggi Angel, Ph.D.
Associate  Professor
Systems-based Approaches to Heart Valve Development and Disease

Lauren E. Ball, Ph.D.
Associate Professor
Role of O-GlcNAc Glycosylation in the Regulation of Insulin/IGF-1 Receptor Signal Transduction Pathways

Jennifer R. Bethard, M.S.
Research Associate
Mass Spectrometry

Joe B. Blumer, Ph.D.
Associate Professor
Role of G-protein Regulatory (GPR) Proteins in Mammalian Cell Division and the Immune System

Nathan Dolloff, Ph.D.
Assistant Professor
Drug Discovery Focus in B and Plasma Cell Malignancies

Richard R. Drake, Jr., Ph.D.
Glycoprotein Biomarkers of Cancer and Mass Spectrometry Imaging

Scott T. Eblen, Ph.D.
Associate Professor
Signal Transduction in Cancer Biology

Xueliang Gao, Ph.D.
Assistant Professor
Tumorigenesis and translational oncology

Guy Aaron Hobbs
Aaron Hobbs, Ph.D.
Assistant Professor
Currently setting up laboratory

Lalima Ahuja
Lalima K. Madan, Ph.D.
Assistant Professor
Protein-Phosphorylation based Signaling

Anand Mehta, D.Phil
Biomarker discovery

John P. O'Bryan, Ph.D.
Signal transduction, scaffold proteins, cancer, RAS, GTPases, intersectin

Steven A. Rosenzweig, Ph.D.
Growth Factor Dysregulation in Cancer

Russell Spencer-Smith, Ph.D.
Russell Spencer-Smith
Assistant Professor
Uncovering new vulnerabilities in the RAS-MAPK pathway through the study of rare disease-associated mutations

Kenneth D. Tew, Ph.D., DSc
Professor and Department Chairman
Cancer Drug Development

Haizhen Wang, Ph.D.
Assistant Professor
Cell cycle proteins in cancer progression

Zhiwei Ye 
Zhiwei Ye, Ph.D.
Research Associate Professor
Redox and drug development in cancer


Jie Zhang, Ph.D.
Research Associate Professor
Redox and drug development in cancer